Company news

Lifecore Biomedical, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment

December 18, 2024

Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO

November 25, 2024

Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024

November 6, 2024

Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations

November 3, 2024

Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update

October 3, 2024

Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock

October 3, 2024

Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational

September 18, 2024

Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements

September 11, 2024

Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources

September 9, 2024

Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 5, 2024

Lifecore Biomedical Announces Chief Financial Officer Transition

August 28, 2024

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update

August 25, 2024

Lifecore Biomedical Announces Cooperation Agreement with 22NW

June 30, 2024

Lifecore Biomedical Completes Incremental Liquidity Initiatives

May 15, 2024

Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress

March 31, 2024

Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update

March 25, 2024

Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023

March 19, 2024

Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal

February 15, 2024

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

January 4, 2024

Lifecore Biomedical Provides Business Update

December 12, 2023

Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods

November 19, 2023

Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results

August 30, 2023

Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7: 30 a.m. CT

August 21, 2023

Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results

May 31, 2023

Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer

May 21, 2023

Lifecore Biomedical Announces Sale of Curation Foods’ O Olive Oil and Vinegar® Business

April 5, 2023

Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results

March 15, 2023

Lifecore Biomedical Announces Intent to Explore Strategic Alternatives

March 15, 2023

Lifecore Biomedical Announces Sale of Curation Foods’ Avocado Products Business

February 6, 2023

Lifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities

January 8, 2023

Lifecore Biomedical Raises Capital for Growth with Existing Stockholder

November 24, 2022

Lifecore Biomedical Announces Completion of Corporate Name Change

November 13, 2022

Lifecore to Manufacture New Innovative Drug for Treatment of Postoperative Pain Following Customer’s FDA Approval

May 16, 2021

Landec Announces Dawn Kimball as New Senior Vice President, Chief People Officer

October 30, 2019

← Newer news releases

Calls

The 5 newest of 19 calls. Every call is listed under its year.

Decks

The 5 newest of 17 decks. Every deck is listed under its year.